Their investigation revealed the presence of increased levels of DNMT1 and TMSB10 expression, diminished miR‐152‐3p expression and methylated miR‐152‐3p in both CRC tissues and cells. This evidence concerns the gene TMSB10 and colorectal carcinoma.